Member Info for JRDC

@madmag - analogy would be my mr2 is worth £1000, I'm keeping it as it might become a future classic worth £10000. If some bloke offered me £5000 now would I take it? Yeah, I probably would.

I wouldn't put too much hope on being a 'clinical' company to propel the SP.

Avacta were £2.50+ when still in 'pre clinical' phase, it now bounces between £1.10 and £1.20 several months in to phase 1 clinical trials, which have since expanded, on a potential game changing drug, where good news is almost expected rather than hoped for.

12-24 months from now though will see the sp of both companies multiples of where they are now, which is fine for me

Next RNS to be a placing then, given HUA seems unlikely this winter (for any British LFT). Best off doing it now in the 20's with a 25% discount rather than 10's.

Wow, so Colin 'assumed' he could use the prepayment funds to upgrade omegas facilities. Why didn't he ask them?! Comical incompetence, thank fook I only put £500 here at 50p, that'll be worth £50 in a few weeks. Who's gonna be down the job centre first, Colin or BoJo?

Will someone check on BigJock and MerchantBanker, gonna be a shoite Christmas for them.

Shame its 'may require', not 'will require', doesn't sound like significant concrete orders yet, initial order seems to be fewer than 1m otherwise it will have been worded differently. I think current production capacity is measured in thousands which is why this 'significant' order is going to abdx (but less than 1m / month required). HUA could change all this, not that I'm ever expecting HUA in UK. Was hoping we wouldn't have to rely on medusa to make the LFT a success but that's the twats in govt for you.

Ffs I sound like NDN. Apologies. Still, possibly 2 months or less for some initial data on ava which could be game changing.

And aren't they going to start charging western countries soon? Try out the 1st gen vaccines at cost, get a free clinical trial, develop a far more advanced version that can work against future strains and charge a fortune for it. Home testing could well end up being a cheaper method of containing the virus for us plebs

Odx situation showing how crazy our valuation is. I had a tiny punt there on the hope of a govt contract, have written that off now.
I agree, I think people are looking at likes of gdr, brh, odx all pumped on hype and now wanting something stable. Until HUA comes in for avacta and odx the short term potential Is here, a positive resolution of dispute could see the SP double from here. I'm of the opinion HUA will not be granted until 2022, and resolution could well happen in December.

I think a lot of people owe you an apology, esp Calderkate. But they won't, ego, pride and arrogance will get in the way. Instead they'll resort back to insults if it rises by 0.5% tomorrow.

Might as well get the placing over and done with, better to do it now and hopefully get 20p a share rather than wait 12 months and raise 2p a share when cash balance will be dangerously low.

Maybe they mean pantomime?

HUA is imminent

"oh no it isn't"

Board aren't buying either because it could be seen as insider info if suddenly next month they release an RNS saying dhsc have paid up in full with 9% interest, or they're aware that the dispute is likely to go against them.

Hoping its the former, even if dispute does find against nova, I can't see the SP dropping much below £2 so from here I think we're about as low as we can go, unless covid suddenly disappears. Then again this share is bonkers so I've given up trying to predict what might happen.

Kate - no need to be sarcastic.

Glad I didn't bother voting.

No direction, no communication, no promised acquisitions, no LFT, no sign of resolution. What an absolute shambles of a year after so much promise and progress in 2020. At least Colin King and wallbrook over at omega had the decency to warn investors not to pop down to the tesla dealership.

Not expecting to see another red dot in RNS tab until Feb. I just hope this silence is because they're waiting for resolution in next few months, not that they don't have a clue how to adapt to a world no longer scared of covid

@Jimi - Omega has branched in to the "Self Storage" business and got one over our main competitor Big Yellow by winning a Govt contract to store some machinery for 12 months, could be worth several grand a month with the Sq footage taken.

The type of Lateral Flow Antigen Test we provide is recognised as Hughes Health Care Sars-CoV-2 SARS-CoV-2 Antigen Test. It is registered through PHE.

Our Lateral Flow Antigen Tests accuracy, sensitivity and specificity can be found below:

Sensitivity: 96.8%

Specificity: 97.1%

Accuracy: 98.8%

The manufacturer of our Lateral Flow Antigen Tests is titled ACON Biotech (Hangzhou) Co. Ltd. Our Lateral Flow Antigen Tests are recognised under Annex 1

CK woke up this morning, chuckled to himself at the novacyt and avacta RNS, and then he thought "Wait, what's this deadline they're speaking of?"

Just hope the new CEOs first RNS isn't a speeding ticket

Great read, good balanced arguments. I think the BBI partnership has been canned since they were bought out due to them not being able to meet costs (shows Al is aware that cost will be a primary factor) , but AS seems pretty keen to promote manufacturing capacity outside of UK which can be quickly scaled up.

Look at the logistics of getting tests to market with HGV driver shortages, manufacturing will need to take place close to demand, if we can have manufacturing bases in UK, spain, Asia etc if puts us at an advantage, a manufacturer only residing in far east or US will struggle to meet orders, govt ain't gonna charter planes forever, and alls gone quiet on that innova Welsh factory

Mologics test using optimer ligands didnt use animals in development, nor reliant on any immune system, so it wouldnt be a unique selling point for avacta.

If they wanted shareholders to vote in droves, they would have released Q3 this week if they were inline with or exceeding expectations, and can then turn around and say "support us, look how well things are going", GM could have left on a high, shareholders welcome new CEO with optimism.

All eyes on dispute resolution now, I'll be selling my holding on that, win lose or draw. Would love to see £5 again just to get out with some profit and not write the last 8 months off